海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09989 海普瑞

已收盘 11-09 16:08:03

4.035

-0.020

-0.49%

最高4.065	最低3.970	成交量19.70万
今开3.980	昨收4.055	日振幅2.34%
总市值59.19亿	流通市值8.88亿	总股本14.67亿
成交额78.93万	换手率0.09%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09989","market":"HK","secType":"STK","nameCN":"海普瑞","latestPrice":4.035,"timestamp":1794211683576,"preClose":4.055,"halted":0,"volume":197000,"delay":0,"changeRate":-0.004932182490752053,"floatShares":220094500,"shares":1467000000,"eps":0.2800181801072739,"marketStatus":"已收盘","change":-0.02,"latestTime":"11-09 16:08:03","open":3.98,"high":4.065,"low":3.97,"amount":789297,"amplitude":0.023428,"askPrice":4.035,"askSize":3500,"bidPrice":3.98,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.15209266214986983,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794274200000},"marketStatusCode":5,"adr":0,"listingDate":1594137600000,"exchange":"SEHK","adjPreClose":4.055,"dividendRate":0.042222,"openAndCloseTimeList":[[1794187800000,1794196800000],[1794200400000,1794211200000]],"volumeRatio":0.72855,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002399","market":"SZ","secType":"STK","nameCN":"海普瑞","latestPrice":9.32,"timestamp":1794207600000,"preClose":9.44,"halted":0,"volume":2856000,"delay":0,"premium":"-63.17"}},"requestUrl":"/m/hq/s/09989","defaultTab":"news","newsList":[{"id":"2681133813","title":"海普瑞新注册《肝素效价设备运行故障预警诊断系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2681133813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681133813?lang=zh_cn&edition=full","pubTime":"2026-11-07 09:39","pubTimestamp":1794015540,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海普瑞（002399）新注册了《肝素效价设备运行故障预警诊断系统V1.0》项目的软件著作权。今年以来海普瑞新注册软件著作权1个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了8232.97万元，同比减19.85%。通过天眼查大数据分析，深圳市海普瑞药业集团股份有限公司共对外投资了14家企业，参与招投标项目34次；财产线索方面有商标信息121条，专利信息55条，著作权信息4条；此外企业还拥有行政许可131个。数据来源：企查查以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110700010356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159180","BK0070","09989","BK1191","BK0188","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116705094","title":"海普瑞10月股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1116705094","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116705094?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:36","pubTimestamp":1793694982,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司于2026年11月3日公布2026年10月（截至10月31日）股份变动月报表。报告显示，海普瑞本月未有新增发行、回购或注销行为，股本保持稳定。\n截至2026年10月末，海普瑞注册股本合计为人民币1,467,296,204元，所对应已发行股份总数为1,467,296,204股，其中包括220,094,500股H股及1,247,201,704股A股，均相较上月无变化。公司并无任何库存股，亦无发生任何购回、注销或股票期权、可换股票据及其他股权激励计划方面的变动。\n公司同时确认已遵守香港联合交易所有限公司相关上市规则及适用法律的要求。公告由联席公司秘书钱风奇签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680781827","title":"股市必读：海普瑞三季报 - 第三季度单季净利润同比下降9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680781827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680781827?lang=zh_cn&edition=full","pubTime":"2026-11-02 09:54","pubTimestamp":1793584480,"startTime":"0","endTime":"0","summary":"业绩披露要点：海普瑞2026年前三季度归母净利润3.94亿元，同比下降28.84%；扣非净利润2.41亿元，同比下降56.24%。公司公告汇总2026年三季度报告海普瑞2026年第三季度报告显示，本报告期营业收入1,217,331,210.60元，同比下降11.60%；归属于上市公司股东的净利润118,613,610.40元，同比下降9.95%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200006657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679801102","title":"图解海普瑞三季报：第三季度单季净利润同比下降9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679801102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679801102?lang=zh_cn&edition=full","pubTime":"2026-10-30 01:58","pubTimestamp":1793296687,"startTime":"0","endTime":"0","summary":"证券之星消息，海普瑞2026年三季报显示，前三季度公司主营收入37.97亿元，同比下降9.48%；归母净利润3.94亿元，同比下降28.84%；扣非净利润2.41亿元，同比下降56.24%；其中2026年第三季度，公司单季度主营收入12.17亿元，同比下降11.6%；单季度归母净利润1.19亿元，同比下降9.95%；单季度扣非净利润7956.87万元，同比下降36.72%；负债率27.23%，投资收益2873.77万元，财务费用2.08亿元，毛利率34.37%。财报数据概要请见下图:本文数据来源于海普瑞2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000004161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09989","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679289558","title":"海普瑞（002399）披露2026年三季度报告，10月29日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679289558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679289558?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:42","pubTimestamp":1793284958,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，海普瑞报收于9.08元，较前一交易日下跌1.41%，最新总市值为133.23亿元。该股当日开盘9.18元，最高9.24元，最低9.07元，成交额达1830.96万元，换手率为0.16%。近日，海普瑞披露《2026年三季度报告》。报告显示，本报告期营业收入1,217,331,210.60元，同比下降11.60%；归属于上市公司股东的净利润118,613,610.40元，同比下降9.95%。年初至报告期末营业收入3,796,852,981.20元，同比下降9.48%；归属于上市公司股东的净利润393,898,350.51元，同比下降28.84%。扣除非经常性损益后的净利润为241,469,533.96元，同比下降56.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900063773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002399","BK0239","BK1191","BK0188","BK0070","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118034727","title":"海普瑞（09989）董事会审议通过三项议案 核心文件同步披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1118034727","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118034727?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:51","pubTimestamp":1793263898,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司（09989）10月30日公告称，公司第七届董事会第三次会议已于2026年10月29日14:00在深圳市南山区松坪山朗山路21号召开。本次会议应参会并表决董事7人，实际参会并表决董事7人，符合法定程序。会议由董事长李锂主持。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172966612","title":"海普瑞（09989.HK）调整联席公司秘书及授权代表 2026年10月29日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1172966612","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172966612?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:45","pubTimestamp":1793263540,"startTime":"0","endTime":"0","summary":"10月29日，海普瑞公告称，因工作安排调整，陈诗婷已辞任联席公司秘书及香港联交所证券上市规则第3.05条规定的授权代表，同时，她与黄慧儿已辞去根据上市规则第19.05条规定在香港接收法律程序文件及通知的代理人职务，上述变动自2026年10月29日起生效。公司表示，陈诗婷及黄慧儿确认与董事会并无分歧，亦无其他事项需提请股东及联交所关注。公司董事会对陈诗婷和黄慧儿的贡献表示感谢，并欢迎陈佩贞加入。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122536434","title":"海普瑞(09989)披露2026年三季报：前九个月营收37.97亿元，同比降9.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1122536434","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122536434?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:45","pubTimestamp":1793263534,"startTime":"0","endTime":"0","summary":"2026年10月29日，深圳市海普瑞药业集团股份有限公司发布截至2026年9月30日的第三季度报告。2026年第三季度，公司实现营业收入12.17亿元，同比下降11.60%；归属于上市公司股东的净利润1.19亿元，同比下降9.95%；扣除非经常性损益后净利润0.80亿元，同比下降36.72%。2026年前三季度，公司营业收入37.97亿元，同比下降9.48%；归属于上市公司股东的净利润3.94亿元，同比下降28.84%；扣非后净利润2.41亿元，同比下降56.24%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679473941","title":"海普瑞(09989)：陈佩贞获委任为联席公司秘书、授权代表及代理人","url":"https://stock-news.laohu8.com/highlight/detail?id=2679473941","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679473941?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:45","pubTimestamp":1793263527,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布公告，陈诗婷女士由于工作安排调整，已辞任本公司联席公司秘书及根据香港联合交易所有限公司证券上市规则第3.05条的授权代表自2026年10月29日起生效。董事会进一步宣布陈女士及黄慧儿女士已辞任根据上市规则第19.05(2)条规定代表本公司在香港接收法律程序文件及通知的代理人，自2026年10月29日起生效。陈佩贞女士已获委任为联席公司秘书、授权代表及代理人，自2026年10月29日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09989","BK1191","002399","BK0070","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679473910","title":"海普瑞(09989)前三季度归母净利润3.94亿元 同比减少28.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679473910","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679473910?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:44","pubTimestamp":1793263481,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海普瑞(09989)发布2026年前三季度业绩，该集团取得营业收入37.97亿元人民币，同比减少9.48%;归属于上市公司股东的净利润3.94亿元，同比减少28.84%;基本每股收益0.2685元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515078.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002399","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675815594","title":"洪泽君增持海普瑞(09989.HK)48.7万股 每股作价3.97港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675815594","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675815594?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:59","pubTimestamp":1792151944,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09989","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110491246","title":"海普瑞（09989）将于10月29日召开董事会审议2026年前三季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1110491246","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110491246?lang=zh_cn&edition=full","pubTime":"2026-10-16 16:36","pubTimestamp":1792139777,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司（09989）10月16日发布公告称，公司董事会计划于2026年10月29日（星期四）举行会议，审议并通过集团截至2026年9月30日止九个月的第三季度业绩及其公告事宜。公告同时列出公司现任董事名单，包括执行董事李锂、李坦、单宇、王建一，以及独立非执行董事黄鹏、易铭、浦洪。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674872767","title":"洪泽君增持海普瑞(09989.HK)30.65万股 每股作价约3.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674872767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674872767?lang=zh_cn&edition=full","pubTime":"2026-10-12 19:36","pubTimestamp":1791804990,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09989","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049099","title":"海普瑞（002399）9月30日主力资金净买入151.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049099?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:09","pubTimestamp":1791421740,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，海普瑞报收于9.85元，上涨2.5%，换手率0.33%，成交量4.15万手，成交额4078.03万元。近5日资金流向一览见下表：海普瑞融资融券信息显示，融资方面，当日融资买入194.78万元，融资偿还676.35万元，融资净偿还481.57万元。海普瑞主营业务：肝素产业链、生物大分子CDMO和创新药物的投资、开发及商业化,致力于为全球患者带去高质量的安全有效药物和服务,护佑健康。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800003036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","09989","BK1191","BK0188","002399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141520435","title":"海普瑞更新2026年9月股份变动月报，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1141520435","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141520435?lang=zh_cn&edition=full","pubTime":"2026-10-05 16:37","pubTimestamp":1791189436,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司于2026年10月5日发布的2026年9月股份变动月报显示，截至2026年9月30日，公司股本结构保持稳定，未发生新增发行、回购或库藏股变动。根据公告，海普瑞的法定/注册股本维持不变，分别为H股220,094,500股和A股1,247,201,704股，合计法定/注册股本总额为人民币1,467,296,204元。另据披露，海普瑞当月未有股份期权、权证或可转债等相关发行及行使活动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671261838","title":"海普瑞（002399）9月28日主力资金净买入397.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671261838","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671261838?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:09","pubTimestamp":1790644143,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，海普瑞报收于9.66元，上涨0.84%，换手率0.26%，成交量3.23万手，成交额3111.17万元。近5日资金流向一览见下表：海普瑞融资融券信息显示，融资方面，当日融资买入426.65万元，融资偿还351.53万元，融资净买入75.11万元。海普瑞主营业务：肝素产业链、生物大分子CDMO和创新药物的投资、开发及商业化,致力于为全球患者带去高质量的安全有效药物和服务,护佑健康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900008288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","09989","BK0239","002399","BK0070","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488634","title":"洪泽君增持海普瑞(09989.HK)34.25万股 每股作价3.9港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488634","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669488634?lang=zh_cn&edition=full","pubTime":"2026-09-23 19:13","pubTimestamp":1790162023,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09989","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172227498","title":"海普瑞：洪泽君增持，好仓比例升至12.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1172227498","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172227498?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:23","pubTimestamp":1790155428,"startTime":"0","endTime":"0","summary":"洪泽君于2026年9月22日在联交所场内以每股均价3.9000港元买入海普瑞（09989）股份34.25万股，涉资约133.57万港元，属场内主动交易，即在二级市场直接买卖股份。洪泽君此次增持前持有海普瑞好仓2639.45万股，占比11.99%；增持后持股量为2673.70万股，好仓比例升至12.14%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669396121","title":"股市必读：海普瑞新发布《深圳市海普瑞药业集团股份有限公司2026年第一次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669396121","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669396121?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:18","pubTimestamp":1790101090,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司2026年第一次临时股东会决议公告深圳市海普瑞药业集团股份有限公司于2026年9月22日召开2026年第一次临时股东会，会议由董事会召集，董事长李锂主持，采取现场与网络投票结合方式召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002399","BK1191","BK0070","BK0188","09989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168075351","title":"海普瑞（09989）2026年首场临时股东大会通过两项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=1168075351","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168075351?lang=zh_cn&edition=full","pubTime":"2026-09-22 19:05","pubTimestamp":1790075141,"startTime":"0","endTime":"0","summary":"深圳市海普瑞药业集团股份有限公司9月22日披露，其2026年第一次临时股东大会以现场及网络方式表决通过全部议案。会议于2026年9月22日14时在深圳市南山区南海大道3031号兰赫美特酒店二楼宴会厅举行。截至股东大会当日，公司已发行股份总数为1,467,296,204股，其中A股1,247,201,704股，H股220,094,500股。本次大会股东及受托代表实际出席并参与表决的股份总数为992,838,085股，占公司已发行股份总数的67.66%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09989"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0305},{"period":"1month","weight":0.0629},{"period":"3month","weight":-0.0459},{"period":"6month","weight":-0.1472},{"period":"1year","weight":-0.2284},{"period":"ytd","weight":-0.1914}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市海普瑞药业集团股份有限公司是一家主要从事肝素产业链、生物大分子合同开发和生产组织（CDMO）和创新药物的投资、开发及商业化的中国公司。该公司运营四个分部。药品制剂分部生产和销售依诺肝素钠注射液等。原料药物分部生产和销售标准肝素活性药物和依诺肝素活性药物等。CDMO分部提供药物的中间体和原料药工艺研发服务，包括工艺研究、优化、分析检测、制剂研究等。其他分部从事其他产品业务，如胰酶、肠衣等。该公司在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.055012},{"month":2,"riseRate":0.5,"avgChangeRate":0.044203},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.066279},{"month":4,"riseRate":0.5,"avgChangeRate":0.026442},{"month":5,"riseRate":0.666667,"avgChangeRate":0.011756},{"month":6,"riseRate":0.333333,"avgChangeRate":0.009474},{"month":7,"riseRate":0.5,"avgChangeRate":0.026975},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.021639},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.053755},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.028288},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.004363},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.022578}],"exchange":"SEHK","name":"海普瑞","nameEN":"HEPALINK"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海普瑞,09989,海普瑞股票,海普瑞股票老虎,海普瑞股票老虎国际,海普瑞行情,海普瑞股票行情,海普瑞股价,海普瑞股市,海普瑞股票价格,海普瑞股票交易,海普瑞股票购买,海普瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海普瑞(09989)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海普瑞(09989)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}